The longer patients were treated with metformin after being diagnosed with prostate cancer, the greater their survival rates were, depending on the dose they were given….
Read More »Efficacy of DPP-4 Inhibitors and Metformin as Initial Combo Therapy in Type 2 Diabetes
DPP-4 may be a credible alternative for patients unable to tolerate metformin….
Read More »Increasing Longevity with Metformin
Daily doses of metformin improved the metabolism and increased the lifespans of middle-aged male mice….
Read More »Metformin Fails to Improve Survival Rates in Breast Cancer Patients
In a select sample of breast cancer patients, the possible anti-cancer effects of metformin do not significantly increase survival rates….
Read More »Metformin May Slow Aging Process
Worms treated with metformin live longer. The drug may slow the aging process by mimicking the effects of dieting….
Read More »Metformin May Delay Aging and Cancer Progression
Metformin delays aging and cancer progression by reducing the production of….
Read More »Metformin or Glipizide to Prevent Cardiovascular Events?
Compared with glipizide, long-term therapy with metformin leads to a reduction in major cardiovascular events in patients with type 2 diabetes….
Read More »Metformin Reduces Blood Glucose and Weight in Obese Children
Severely obese children and adolescents who took 1.5 g metformin daily reduced their body mass index SD scores (BMI-SDS) by 3% at 6 months without making significant changes to their diets and physical activity levels….
Read More »Diabetes Drug Metformin May Fight Ovarian Cancer
Ovarian cancer patients who took the drug metformin survived longer than patients who did not take it….
Read More »Metformin Effective for Obese Children
When used as a treatment for children with hyperinsulinemia and or IFG or IGT, researchers found that it was also linked to a significant reduction in BMI….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.